Literature DB >> 17287373

Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs.

Dennis McCarty1, Bret E Fuller, Cynthia Arfken, Michael Miller, Edward V Nunes, Eldon Edmundson, Marc Copersino, Anthony Floyd, Robert Forman, Reesa Laws, Kathy M Magruder, Mark Oyama, Kristi Prather, Jody Sindelar, William W Wendt.   

Abstract

OBJECTIVE: Individuals with direct care responsibilities in 348 drug abuse treatment units were surveyed to obtain a description of the workforce and to assess support for evidence-based therapies.
METHODS: Surveys were distributed to 112 programs participating in the National Drug Abuse Treatment Clinical Trials Network (CTN). Descriptive analyses characterized the workforce. Analyses of covariance tested the effects of job category on opinions about evidence-based practices and controlled for the effects of education, modality (outpatient or residential), race, and gender.
RESULTS: Women made up two-thirds of the CTN workforce. One-third of the workforce had a master's or doctoral degree. Responses from 1,757 counselors, 908 support staff, 522 managers-supervisors, and 511 medical staff (71% of eligible participants) suggested that the variables that most were most consistently associated with responses were job category (19 of 22 items) and education (20 of 22 items). Managers-supervisors were the most supportive of evidence-based therapies, and support staff were the least supportive. Generally, individuals with graduate degrees had more positive opinions about evidence-based therapies. Support for using medications and contingency management was modest across job categories.
CONCLUSIONS: The relatively traditional beliefs of support staff could inhibit the introduction of evidence-based practices. Programs initiating changes in therapeutic approaches may benefit from including all employees in change efforts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287373      PMCID: PMC2861362          DOI: 10.1176/appi.ps.58.2.181

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  11 in total

1.  Staff beliefs about addiction treatment.

Authors:  R F Forman; G Bovasso; G Woody
Journal:  J Subst Abuse Treat       Date:  2001-07

2.  Assessing organizational readiness for change.

Authors:  Wayne E K Lehman; Jack M Greener; D Dwayne Simpson
Journal:  J Subst Abuse Treat       Date:  2002-06

3.  A conceptual framework for transferring research to practice.

Authors:  D Dwayne Simpson
Journal:  J Subst Abuse Treat       Date:  2002-06

4.  A national study of the substance abuse treatment workforce.

Authors:  Kevin P Mulvey; Susan Hubbard; Susan Hayashi
Journal:  J Subst Abuse Treat       Date:  2003-01

5.  Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Authors:  Nancy M Petry; Jessica M Peirce; Maxine L Stitzer; Jack Blaine; John M Roll; Allan Cohen; Jeanne Obert; Therese Killeen; Michael E Saladin; Mark Cowell; Kimberly C Kirby; Robert Sterling; Charlotte Royer-Malvestuto; John Hamilton; Robert E Booth; Marilyn Macdonald; Marc Liebert; Linda Rader; Raynetta Burns; Joan DiMaria; Marc Copersino; Patricia Quinn Stabile; Ken Kolodner; Rui Li
Journal:  Arch Gen Psychiatry       Date:  2005-10

6.  A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.

Authors:  Walter Ling; Leslie Amass; Steve Shoptaw; Jeffrey J Annon; Maureen Hillhouse; Dean Babcock; Greg Brigham; Judy Harrer; Malcolm Reid; Joan Muir; Betty Buchan; Debbie Orr; George Woody; Jonathan Krejci; Douglas Ziedonis
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

7.  Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study.

Authors:  Kathleen M Carroll; Samuel A Ball; Charla Nich; Steve Martino; Tami L Frankforter; Christiane Farentinos; Lynn E Kunkel; Susan K Mikulich-Gilbertson; Jon Morgenstern; Jeanne L Obert; Doug Polcin; Ned Snead; George E Woody
Journal:  Drug Alcohol Depend       Date:  2005-09-28       Impact factor: 4.492

8.  Research to practice: adoption of naltrexone in alcoholism treatment.

Authors:  Cindy Parks Thomas; Stanley S Wallack; Sue Lee; Dennis McCarty; Robert Swift
Journal:  J Subst Abuse Treat       Date:  2003-01

9.  Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Authors:  Leslie Amass; Walter Ling; Thomas E Freese; Chris Reiber; Jeffrey J Annon; Allan J Cohen; Dennis McCarty; Malcolm S Reid; Lawrence S Brown; Cynthia Clark; Douglas M Ziedonis; Jonathan Krejci; Susan Stine; Theresa Winhusen; Greg Brigham; Dean Babcock; Joan A Muir; Betty J Buchan; Terry Horton
Journal:  Am J Addict       Date:  2004

10.  Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.

Authors:  Kathleen M Carroll; Lisa R Fenton; Samuel A Ball; Charla Nich; Tami L Frankforter; Julia Shi; Bruce J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2004-03
View more
  54 in total

1.  Substance abuse treatment counselors and tobacco use: a comparison of comprehensive and indoor-only workplace smoking bans.

Authors:  Hannah K Knudsen; Sara E Boyd; Jamie L Studts
Journal:  Nicotine Tob Res       Date:  2010-09-02       Impact factor: 4.244

2.  Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations.

Authors:  Hannah K Knudsen; Carrie B Oser; Amanda J Abraham; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-02-01

3.  Workforce professionalism in drug treatment services: impact of California's Proposition 36.

Authors:  Fei Wu; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2010-10-30

4.  Attitudes toward the integration of smoking cessation treatment into drug abuse clinics.

Authors:  Bret E Fuller; Joseph Guydish; Janice Tsoh; Malcolm S Reid; Michael Resnick; Lucy Zammarelli; Douglas M Ziedonis; Clare Sears; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2006-09-26

5.  Organizational Readiness for Change and opinions toward treatment innovations.

Authors:  Bret E Fuller; Traci Rieckmann; Edward V Nunes; Michael Miller; Cynthia Arfken; Eldon Edmundson; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2007-04-16

6.  I heard about it from a friend: assessing interest in buprenorphine treatment.

Authors:  Aaron D Fox; Pooja A Shah; Nancy L Sohler; Carolina M Lopez; Joanna L Starrels; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

7.  Organizational implementation of evidence-based substance abuse treatment in racial and ethnic minority communities.

Authors:  Erick G Guerrero; Amy He; Ahraemi Kim; Gregory A Aarons
Journal:  Adm Policy Ment Health       Date:  2014-11

8.  Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Dennis McCarty; Bret Fuller; Lee Ann Kaskutas; William W Wendt; Edward V Nunes; Michael Miller; Robert Forman; Kathryn M Magruder; Cynthia Arfken; Marc Copersino; Anthony Floyd; Jody Sindelar; Eldon Edmundson
Journal:  Drug Alcohol Depend       Date:  2007-09-17       Impact factor: 4.492

9.  Statewide adoption and initial implementation of contingency management for substance-abusing adolescents.

Authors:  Scott W Henggeler; Jason E Chapman; Melisa D Rowland; Colleen A Halliday-Boykins; Jeff Randall; Jennifer Shackelford; Sonja K Schoenwald
Journal:  J Consult Clin Psychol       Date:  2008-08

10.  Disseminating contingency management: impacts of staff training and implementation at an opiate treatment program.

Authors:  Bryan Hartzler; T Ron Jackson; Brinn E Jones; Blair Beadnell; Donald A Calsyn
Journal:  J Subst Abuse Treat       Date:  2013-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.